CSF2 and Sepsis: On the basis of our observations, it remains to be established whether the use of recombinant GM-CSF, which is widely used in human therapy mainly in the oncology [37] and sepsis [38] fields, would represent a therapeutic tool for promoting clinical remission of CVD in alternative to surgical ablation.